Precedex Goes Generic

[Anonymous]

Is Dyloject even FDA approved in U.S.A ?

hr4u

That's what we've been told.

 

[Anonymous]

it's a lie by unscrupulous management

 

[Anonymous]

you r high.
Lets look at the last two launches

Cumberland Pharma with its IV NSAID (caldolor) sold 4 million in the first year which was based on sales to wholesaler not hospital. almost No hospitals bought it and the following year the wholesalers returned 2 million to Cumberland for a sales of minus 2 million. In year three they sold 300,000. Year four 1.5 million. These are not typos. Read their qterly reports.

Cadence sold 8million IV APAp( Ofiremv) first full year. Sales booked by actual purchase from hospital. Second year 56 million, third year 110 million and fourth year after huge price increase they havent said yet but the street is saying 190-200 million.

Caldalor($10 a dose) message was no bleed risk which was a benefit over toradol (generic for 2 bucks.)
Ofiremv ( $11) said only IV APAP. so not like caldalor fighting against an established and generic nsaid.

If the strategy is have the torodal line go down with particulate matter and sell dyloject for $4 that could work